Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction
AUTOR(ES)
Yang, Hailin
FONTE
American Society for Clinical Investigation
RESUMO
The EGF-like domain of smallpox growth factor (SPGF) targets human ErbB-1, inducing tyrosine phosphorylation of certain host cellular substrates via activation of the receptor’s kinase domain and thereby facilitating viral replication. Given these findings, low molecular weight organic inhibitors of ErbB-1 kinases might function as antiviral agents against smallpox. Here we show that CI-1033 and related 4-anilinoquinazolines inhibit SPGF-induced human cellular DNA synthesis, protein tyrosine kinase activation, and c-Cbl association with ErbB-1 and resultant internalization. Infection of monkey kidney BSC-40 and VERO-E6 cells in vitro by variola strain Solaimen is blocked by CI-1033, primarily at the level of secondary viral spreading. In an in vivo lethal vaccinia virus pneumonia model, CI-1033 alone promotes survival of animals, augments systemic T cell immunity and, in conjunction with a single dose of anti-L1R intracellular mature virus particle-specific mAb, fosters virtually complete viral clearance of the lungs of infected mice by the eighth day after infection. Collectively, these findings show that chemical inhibitors of host-signaling pathways exploited by viral pathogens may represent potent antiviral therapies.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=546427Documentos Relacionados
- Vaccinia Virus Inhibitors as a Paradigm for the Chemotherapy of Poxvirus Infections
- Mycobacterium tuberculosis signal transduction system required for persistent infections
- Stochastic Simulation of Signal Transduction: Impact of the Cellular Architecture on Diffusion
- Inhibition of tyrosine phosphorylation prevents T-cell receptor-mediated signal transduction.
- Inhibition of duck hepatitis B virus DNA replication by antiviral chemotherapy with ganciclovir-nalidixic acid.